FDA outlines fast path for shots against new virus variants

Bloomberg

23 February 2021 - Variants are already causing problems for testing, treatment.

Drug makers won’t have to perform massive trials for new vaccines or booster shots developed to combat worrisome new variants of the coronavirus, the U.S. FDA said.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Vaccine , Public health , COVID-19